首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Inaccuracy of Calculated LDL-Cholesterol in Type 2 Diabetes: Consequences for Patient Risk Classification and Therapeutic Decisions
【24h】

Inaccuracy of Calculated LDL-Cholesterol in Type 2 Diabetes: Consequences for Patient Risk Classification and Therapeutic Decisions

机译:2型糖尿病中计算的LDL-胆固醇的不准确性:患者风险分类和治疗决策的后果

获取原文
       

摘要

LDL-cholesterol (LDLc) is the main lipid marker in cardiovascular risk estimation and the principal therapeutic target in both diabetic and nondiabetic subjects (1)(2). The designated comparison method for the determination of LDLc, using ultracentrifugation and precipitation, known as “β-quantification” (3), is cumbersome and time-consuming and requires expensive instrumentation and trained personnel. The Friedewald equation (4) {LDLc = total cholesterol ? HDLc ? [triglycerides (in mmol/L)/2.17 or triglycerides (in mg/dL)/5]}, the most frequently used method for the calculation of LDLc, assumes that VLDL particles maintain a nearly constant cholesterol:triglyceride ratio. However, this assumption is invalid in the presence of chylomicronemia and increased VLDL or intermediate-density lipoprotein particles (4)(5)(6)(7).Because diabetic dyslipidemia includes quantitative and qualitative abnormalities in lipoprotein particles, including VLDL and their remnants (8)(9)(10), the use of the Friedewald equation in diabetic patients has been questioned (11)(12)(13). HDL-cholesterol (HDLc), often determined after chemical precipitation of apolipoprotein B (apoB)-containing lipoproteins, has technical drawbacks that could interfere with the accuracy of LDLc calculation (14). New homogeneous, direct methods have improved HDLc determination (15). However, the consequences on patient classification and therapy of using direct, more precise methods for HDLc in the estimation of LDLc by the Friedewald equation have, to our knowledge, not been assessed.We previously proposed an equation that included total triglycerides and cholesterol, and apoB that was more accurate than the Friedewald equation in estimating LDLc (16). Because diabetic dyslipidemia includes hyperapoB (17), an equation that includes apoB in the estimation of LDLc could be of special interest in these patients. Thus, our aims were to ascertain whether a direct HDLc method increases the accuracy of the Friedewald formula, to evaluate an equation that includes apoB in the estimation of LDLc, and …
机译:LDL-胆固醇(LDLc)是心血管风险评估中的主要脂质标记物,也是糖尿病和非糖尿病患者的主要治疗目标(1)(2)。使用超速离心和沉淀法测定LDLc的指定比较方法被称为“β定量”(3),既麻烦又费时,并且需要昂贵的仪器和训练有素的人员。弗里德瓦尔德方程(4){LDLc =总胆固醇? HDLc? [甘油三酸酯(mmol / L)/2.17或甘油三酸酯(mg / dL)/ 5]}是计算LDLc的最常用方法,它假定VLDL颗粒保持几乎恒定的胆固醇:甘油三酸酯比率。然而,这种假设在存在乳糜微粒血症和VLDL或中等密度脂蛋白颗粒增加的情况下是无效的(4)(5)(6)(7)。因为糖尿病性血脂异常包括脂蛋白颗粒(包括VLDL及其残留物)的定量和定性异常(8)(9)(10),在糖尿病患者中使用Friedewald方程受到质疑(11)(12)(13)。通常在含载脂蛋白B(apoB)的脂蛋白化学沉淀后确定HDL-胆固醇(HDLc),其技术缺陷可能会干扰LDLc的计算准确性(14)。新的同质直接方法改善了HDLc的测定(15)。然而,据我们所知,尚未评估使用直接,更精确的HDLc方法通过Friedewald方程估算LDLc对患者分类和治疗的后果,我们先前提出了一个包含总甘油三酸酯和胆固醇的方程式,以及在估计LDLc方面,apoB比Friedewald方程更为精确(16)。由于糖尿病血脂异常包括hyperapoB(17),因此在这些患者中可能需要特别关注LDLc估算中包含apoB的方程式。因此,我们的目标是确定直接HDLc方法是否可以提高Friedewald公式的准确性,评估在估计LDLc时包括apoB的方程式,以及…

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号